世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

女性腫瘍検出ソリューションの世界市場成長(現状と展望) 2023-2029


Global Women's Oncology Detection Solutions Market Growth (Status and Outlook) 2023-2029

女性用腫瘍検出ソリューションの世界市場規模は、2022年の3億2480万米ドルから2029年には6億8300万米ドルに拡大すると予測され、2023年から2029年までのCAGRは11.2%と予測されています。 女性用腫瘍検出ソリュ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2023年5月16日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
102 英語

 

サマリー

女性用腫瘍検出ソリューションの世界市場規模は、2022年の3億2480万米ドルから2029年には6億8300万米ドルに拡大すると予測され、2023年から2029年までのCAGRは11.2%と予測されています。
女性用腫瘍検出ソリューションの米国市場は、2023年から2029年までCAGR %で、2022年の100万米ドルから2029年には100万米ドルに増加すると推定されます。
女性用腫瘍検出ソリューションの中国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
女性用腫瘍検出ソリューションのヨーロッパ市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
世界の主要な女性腫瘍検出ソリューションのプレーヤーは、Roche、Abbott Laboratories、Thermo Fisher Scientific, Inc.、QIAGEN N.V.、BGI、Bio-Rad Laboratories, Inc.、イルミナ、Inc、MolecularMD、Inivoscribe、Incなどをカバーしています。収益面では、世界の2大企業が2022年にほぼ%のシェアを占めています。
LPI(エルピーアイ)の最新リサーチレポート「女性用がん検診ソリューションの業界予測」は、過去の販売実績と2022年の女性用がん検診ソリューションの世界総販売実績を調べ、2023年から2029年の女性用がん検診ソリューションの販売予測について地域や市場分野ごとに包括的に分析したものである。女性用がん検診ソリューションの売上を地域別、市場分野別、サブセクター別に分類し、世界の女性用がん検診ソリューション産業の詳細な分析を百万米ドル単位で提供するものです。
本インサイトレポートでは、世界の女性用腫瘍検出ソリューションの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要な動向を明らかにします。また、本レポートでは、加速する世界の女性用腫瘍検出ソリューション市場におけるこれらの企業の独自のポジションをより良く理解するために、女性用腫瘍検出ソリューションのポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、女性用がん検診ソリューションの世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、アプリケーション別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界の女性用腫瘍検出ソリューションの現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、製品タイプ、用途、主要プレイヤー、主要地域・国別の女性用がん検診ソリューション市場の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
組織検査
血液検査
その他
用途別セグメンテーション
病院
第三者検診機関
その他
本レポートでは、地域別にも市場を分割しています:
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバー範囲、製品ポートフォリオ、市場浸透度を分析した上で選定されています。
ロシュ
アボット・ラボラトリーズ
サーモフィッシャーサイエンティフィック
QIAGEN N.V.
BGI
バイオ・ラッド・ラボラトリーズ・インク
イルミナ、Inc.
モレキュラーMD
インビボスクライブ社(Invivoscribe, Inc.
バイオアッセイシステムズ
ラボコンペア


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Women's Oncology Detection Solutions Market Size 2018-2029
2.1.2 Women's Oncology Detection Solutions Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Women's Oncology Detection Solutions Segment by Type
2.2.1 Tissue Test
2.2.2 Blood Test
2.2.3 Others
2.3 Women's Oncology Detection Solutions Market Size by Type
2.3.1 Women's Oncology Detection Solutions Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
2.4 Women's Oncology Detection Solutions Segment by Application
2.4.1 Hospital
2.4.2 Third-party Medical Examination Institution
2.4.3 Others
2.5 Women's Oncology Detection Solutions Market Size by Application
2.5.1 Women's Oncology Detection Solutions Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
3 Women's Oncology Detection Solutions Market Size by Player
3.1 Women's Oncology Detection Solutions Market Size Market Share by Players
3.1.1 Global Women's Oncology Detection Solutions Revenue by Players (2018-2023)
3.1.2 Global Women's Oncology Detection Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Women's Oncology Detection Solutions Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Women's Oncology Detection Solutions by Regions
4.1 Women's Oncology Detection Solutions Market Size by Regions (2018-2023)
4.2 Americas Women's Oncology Detection Solutions Market Size Growth (2018-2023)
4.3 APAC Women's Oncology Detection Solutions Market Size Growth (2018-2023)
4.4 Europe Women's Oncology Detection Solutions Market Size Growth (2018-2023)
4.5 Middle East & Africa Women's Oncology Detection Solutions Market Size Growth (2018-2023)
5 Americas
5.1 Americas Women's Oncology Detection Solutions Market Size by Country (2018-2023)
5.2 Americas Women's Oncology Detection Solutions Market Size by Type (2018-2023)
5.3 Americas Women's Oncology Detection Solutions Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Women's Oncology Detection Solutions Market Size by Region (2018-2023)
6.2 APAC Women's Oncology Detection Solutions Market Size by Type (2018-2023)
6.3 APAC Women's Oncology Detection Solutions Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Women's Oncology Detection Solutions by Country (2018-2023)
7.2 Europe Women's Oncology Detection Solutions Market Size by Type (2018-2023)
7.3 Europe Women's Oncology Detection Solutions Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Women's Oncology Detection Solutions by Region (2018-2023)
8.2 Middle East & Africa Women's Oncology Detection Solutions Market Size by Type (2018-2023)
8.3 Middle East & Africa Women's Oncology Detection Solutions Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Women's Oncology Detection Solutions Market Forecast
10.1 Global Women's Oncology Detection Solutions Forecast by Regions (2024-2029)
10.1.1 Global Women's Oncology Detection Solutions Forecast by Regions (2024-2029)
10.1.2 Americas Women's Oncology Detection Solutions Forecast
10.1.3 APAC Women's Oncology Detection Solutions Forecast
10.1.4 Europe Women's Oncology Detection Solutions Forecast
10.1.5 Middle East & Africa Women's Oncology Detection Solutions Forecast
10.2 Americas Women's Oncology Detection Solutions Forecast by Country (2024-2029)
10.2.1 United States Women's Oncology Detection Solutions Market Forecast
10.2.2 Canada Women's Oncology Detection Solutions Market Forecast
10.2.3 Mexico Women's Oncology Detection Solutions Market Forecast
10.2.4 Brazil Women's Oncology Detection Solutions Market Forecast
10.3 APAC Women's Oncology Detection Solutions Forecast by Region (2024-2029)
10.3.1 China Women's Oncology Detection Solutions Market Forecast
10.3.2 Japan Women's Oncology Detection Solutions Market Forecast
10.3.3 Korea Women's Oncology Detection Solutions Market Forecast
10.3.4 Southeast Asia Women's Oncology Detection Solutions Market Forecast
10.3.5 India Women's Oncology Detection Solutions Market Forecast
10.3.6 Australia Women's Oncology Detection Solutions Market Forecast
10.4 Europe Women's Oncology Detection Solutions Forecast by Country (2024-2029)
10.4.1 Germany Women's Oncology Detection Solutions Market Forecast
10.4.2 France Women's Oncology Detection Solutions Market Forecast
10.4.3 UK Women's Oncology Detection Solutions Market Forecast
10.4.4 Italy Women's Oncology Detection Solutions Market Forecast
10.4.5 Russia Women's Oncology Detection Solutions Market Forecast
10.5 Middle East & Africa Women's Oncology Detection Solutions Forecast by Region (2024-2029)
10.5.1 Egypt Women's Oncology Detection Solutions Market Forecast
10.5.2 South Africa Women's Oncology Detection Solutions Market Forecast
10.5.3 Israel Women's Oncology Detection Solutions Market Forecast
10.5.4 Turkey Women's Oncology Detection Solutions Market Forecast
10.5.5 GCC Countries Women's Oncology Detection Solutions Market Forecast
10.6 Global Women's Oncology Detection Solutions Forecast by Type (2024-2029)
10.7 Global Women's Oncology Detection Solutions Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Women's Oncology Detection Solutions Product Offered
11.1.3 Roche Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Women's Oncology Detection Solutions Product Offered
11.2.3 Abbott Laboratories Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Abbott Laboratories Main Business Overview
11.2.5 Abbott Laboratories Latest Developments
11.3 Thermo Fisher Scientific, Inc.
11.3.1 Thermo Fisher Scientific, Inc. Company Information
11.3.2 Thermo Fisher Scientific, Inc. Women's Oncology Detection Solutions Product Offered
11.3.3 Thermo Fisher Scientific, Inc. Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.3.5 Thermo Fisher Scientific, Inc. Latest Developments
11.4 QIAGEN N.V.
11.4.1 QIAGEN N.V. Company Information
11.4.2 QIAGEN N.V. Women's Oncology Detection Solutions Product Offered
11.4.3 QIAGEN N.V. Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 QIAGEN N.V. Main Business Overview
11.4.5 QIAGEN N.V. Latest Developments
11.5 BGI
11.5.1 BGI Company Information
11.5.2 BGI Women's Oncology Detection Solutions Product Offered
11.5.3 BGI Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BGI Main Business Overview
11.5.5 BGI Latest Developments
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Bio-Rad Laboratories, Inc. Company Information
11.6.2 Bio-Rad Laboratories, Inc. Women's Oncology Detection Solutions Product Offered
11.6.3 Bio-Rad Laboratories, Inc. Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.6.5 Bio-Rad Laboratories, Inc. Latest Developments
11.7 Illumina, Inc.
11.7.1 Illumina, Inc. Company Information
11.7.2 Illumina, Inc. Women's Oncology Detection Solutions Product Offered
11.7.3 Illumina, Inc. Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Illumina, Inc. Main Business Overview
11.7.5 Illumina, Inc. Latest Developments
11.8 MolecularMD
11.8.1 MolecularMD Company Information
11.8.2 MolecularMD Women's Oncology Detection Solutions Product Offered
11.8.3 MolecularMD Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 MolecularMD Main Business Overview
11.8.5 MolecularMD Latest Developments
11.9 Invivoscribe, Inc.
11.9.1 Invivoscribe, Inc. Company Information
11.9.2 Invivoscribe, Inc. Women's Oncology Detection Solutions Product Offered
11.9.3 Invivoscribe, Inc. Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Invivoscribe, Inc. Main Business Overview
11.9.5 Invivoscribe, Inc. Latest Developments
11.10 BioAssay Systems
11.10.1 BioAssay Systems Company Information
11.10.2 BioAssay Systems Women's Oncology Detection Solutions Product Offered
11.10.3 BioAssay Systems Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 BioAssay Systems Main Business Overview
11.10.5 BioAssay Systems Latest Developments
11.11 Labcompare
11.11.1 Labcompare Company Information
11.11.2 Labcompare Women's Oncology Detection Solutions Product Offered
11.11.3 Labcompare Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Labcompare Main Business Overview
11.11.5 Labcompare Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る



図表リスト

List of Tables
Table 1. Women's Oncology Detection Solutions Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Tissue Test
Table 3. Major Players of Blood Test
Table 4. Major Players of Others
Table 5. Women's Oncology Detection Solutions Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Women's Oncology Detection Solutions Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Table 8. Women's Oncology Detection Solutions Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Women's Oncology Detection Solutions Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Table 11. Global Women's Oncology Detection Solutions Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Women's Oncology Detection Solutions Revenue Market Share by Player (2018-2023)
Table 13. Women's Oncology Detection Solutions Key Players Head office and Products Offered
Table 14. Women's Oncology Detection Solutions Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Women's Oncology Detection Solutions Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Women's Oncology Detection Solutions Market Size Market Share by Regions (2018-2023)
Table 19. Global Women's Oncology Detection Solutions Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Women's Oncology Detection Solutions Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Women's Oncology Detection Solutions Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Women's Oncology Detection Solutions Market Size Market Share by Country (2018-2023)
Table 23. Americas Women's Oncology Detection Solutions Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Table 25. Americas Women's Oncology Detection Solutions Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Table 27. APAC Women's Oncology Detection Solutions Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Women's Oncology Detection Solutions Market Size Market Share by Region (2018-2023)
Table 29. APAC Women's Oncology Detection Solutions Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Table 31. APAC Women's Oncology Detection Solutions Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Table 33. Europe Women's Oncology Detection Solutions Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Women's Oncology Detection Solutions Market Size Market Share by Country (2018-2023)
Table 35. Europe Women's Oncology Detection Solutions Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Table 37. Europe Women's Oncology Detection Solutions Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Women's Oncology Detection Solutions Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Women's Oncology Detection Solutions Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Women's Oncology Detection Solutions Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Women's Oncology Detection Solutions
Table 46. Key Market Challenges & Risks of Women's Oncology Detection Solutions
Table 47. Key Industry Trends of Women's Oncology Detection Solutions
Table 48. Global Women's Oncology Detection Solutions Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Women's Oncology Detection Solutions Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Women's Oncology Detection Solutions Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Women's Oncology Detection Solutions Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Roche Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 53. Roche Women's Oncology Detection Solutions Product Offered
Table 54. Roche Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Abbott Laboratories Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 58. Abbott Laboratories Women's Oncology Detection Solutions Product Offered
Table 59. Abbott Laboratories Main Business
Table 60. Abbott Laboratories Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Abbott Laboratories Latest Developments
Table 62. Thermo Fisher Scientific, Inc. Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 63. Thermo Fisher Scientific, Inc. Women's Oncology Detection Solutions Product Offered
Table 64. Thermo Fisher Scientific, Inc. Main Business
Table 65. Thermo Fisher Scientific, Inc. Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Thermo Fisher Scientific, Inc. Latest Developments
Table 67. QIAGEN N.V. Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 68. QIAGEN N.V. Women's Oncology Detection Solutions Product Offered
Table 69. QIAGEN N.V. Main Business
Table 70. QIAGEN N.V. Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. QIAGEN N.V. Latest Developments
Table 72. BGI Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 73. BGI Women's Oncology Detection Solutions Product Offered
Table 74. BGI Main Business
Table 75. BGI Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. BGI Latest Developments
Table 77. Bio-Rad Laboratories, Inc. Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 78. Bio-Rad Laboratories, Inc. Women's Oncology Detection Solutions Product Offered
Table 79. Bio-Rad Laboratories, Inc. Main Business
Table 80. Bio-Rad Laboratories, Inc. Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Bio-Rad Laboratories, Inc. Latest Developments
Table 82. Illumina, Inc. Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 83. Illumina, Inc. Women's Oncology Detection Solutions Product Offered
Table 84. Illumina, Inc. Main Business
Table 85. Illumina, Inc. Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Illumina, Inc. Latest Developments
Table 87. MolecularMD Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 88. MolecularMD Women's Oncology Detection Solutions Product Offered
Table 89. MolecularMD Main Business
Table 90. MolecularMD Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. MolecularMD Latest Developments
Table 92. Invivoscribe, Inc. Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 93. Invivoscribe, Inc. Women's Oncology Detection Solutions Product Offered
Table 94. Invivoscribe, Inc. Main Business
Table 95. Invivoscribe, Inc. Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Invivoscribe, Inc. Latest Developments
Table 97. BioAssay Systems Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 98. BioAssay Systems Women's Oncology Detection Solutions Product Offered
Table 99. BioAssay Systems Main Business
Table 100. BioAssay Systems Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. BioAssay Systems Latest Developments
Table 102. Labcompare Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 103. Labcompare Women's Oncology Detection Solutions Product Offered
Table 104. Labcompare Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Labcompare Main Business
Table 106. Labcompare Latest Developments
List of Figures
Figure 1. Women's Oncology Detection Solutions Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Women's Oncology Detection Solutions Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Women's Oncology Detection Solutions Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Women's Oncology Detection Solutions Sales Market Share by Country/Region (2022)
Figure 8. Women's Oncology Detection Solutions Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Women's Oncology Detection Solutions Market Size Market Share by Type in 2022
Figure 10. Women's Oncology Detection Solutions in Hospital
Figure 11. Global Women's Oncology Detection Solutions Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Women's Oncology Detection Solutions in Third-party Medical Examination Institution
Figure 13. Global Women's Oncology Detection Solutions Market: Third-party Medical Examination Institution (2018-2023) & ($ Millions)
Figure 14. Women's Oncology Detection Solutions in Others
Figure 15. Global Women's Oncology Detection Solutions Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Women's Oncology Detection Solutions Market Size Market Share by Application in 2022
Figure 17. Global Women's Oncology Detection Solutions Revenue Market Share by Player in 2022
Figure 18. Global Women's Oncology Detection Solutions Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Women's Oncology Detection Solutions Market Size 2018-2023 ($ Millions)
Figure 20. APAC Women's Oncology Detection Solutions Market Size 2018-2023 ($ Millions)
Figure 21. Europe Women's Oncology Detection Solutions Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Women's Oncology Detection Solutions Market Size 2018-2023 ($ Millions)
Figure 23. Americas Women's Oncology Detection Solutions Value Market Share by Country in 2022
Figure 24. United States Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Women's Oncology Detection Solutions Market Size Market Share by Region in 2022
Figure 29. APAC Women's Oncology Detection Solutions Market Size Market Share by Type in 2022
Figure 30. APAC Women's Oncology Detection Solutions Market Size Market Share by Application in 2022
Figure 31. China Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Women's Oncology Detection Solutions Market Size Market Share by Country in 2022
Figure 38. Europe Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Figure 39. Europe Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Figure 40. Germany Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 54. APAC Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 55. Europe Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 57. United States Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 58. Canada Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 61. China Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 62. Japan Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 63. Korea Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 65. India Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 66. Australia Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 67. Germany Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 68. France Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 69. UK Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 70. Italy Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 71. Russia Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 72. Spain Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 75. Israel Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 78. Global Women's Oncology Detection Solutions Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Women's Oncology Detection Solutions Market Size Market Share Forecast by Application (2024-2029)

 

ページTOPに戻る


 

Summary

The global Women's Oncology Detection Solutions market size is projected to grow from US$ 324.8 million in 2022 to US$ 683 million in 2029; it is expected to grow at a CAGR of 11.2% from 2023 to 2029.
United States market for Women's Oncology Detection Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Women's Oncology Detection Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Women's Oncology Detection Solutions is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Women's Oncology Detection Solutions players cover Roche, Abbott Laboratories, Thermo Fisher Scientific, Inc., QIAGEN N.V., BGI, Bio-Rad Laboratories, Inc., Illumina, Inc., MolecularMD and Invivoscribe, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Women's Oncology Detection Solutions Industry Forecast” looks at past sales and reviews total world Women's Oncology Detection Solutions sales in 2022, providing a comprehensive analysis by region and market sector of projected Women's Oncology Detection Solutions sales for 2023 through 2029. With Women's Oncology Detection Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Women's Oncology Detection Solutions industry.
This Insight Report provides a comprehensive analysis of the global Women's Oncology Detection Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Women's Oncology Detection Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Women's Oncology Detection Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Women's Oncology Detection Solutions and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Women's Oncology Detection Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Women's Oncology Detection Solutions market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Tissue Test
Blood Test
Others
Segmentation by application
Hospital
Third-party Medical Examination Institution
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Abbott Laboratories
Thermo Fisher Scientific, Inc.
QIAGEN N.V.
BGI
Bio-Rad Laboratories, Inc.
Illumina, Inc.
MolecularMD
Invivoscribe, Inc.
BioAssay Systems
Labcompare



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Women's Oncology Detection Solutions Market Size 2018-2029
2.1.2 Women's Oncology Detection Solutions Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Women's Oncology Detection Solutions Segment by Type
2.2.1 Tissue Test
2.2.2 Blood Test
2.2.3 Others
2.3 Women's Oncology Detection Solutions Market Size by Type
2.3.1 Women's Oncology Detection Solutions Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
2.4 Women's Oncology Detection Solutions Segment by Application
2.4.1 Hospital
2.4.2 Third-party Medical Examination Institution
2.4.3 Others
2.5 Women's Oncology Detection Solutions Market Size by Application
2.5.1 Women's Oncology Detection Solutions Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
3 Women's Oncology Detection Solutions Market Size by Player
3.1 Women's Oncology Detection Solutions Market Size Market Share by Players
3.1.1 Global Women's Oncology Detection Solutions Revenue by Players (2018-2023)
3.1.2 Global Women's Oncology Detection Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Women's Oncology Detection Solutions Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Women's Oncology Detection Solutions by Regions
4.1 Women's Oncology Detection Solutions Market Size by Regions (2018-2023)
4.2 Americas Women's Oncology Detection Solutions Market Size Growth (2018-2023)
4.3 APAC Women's Oncology Detection Solutions Market Size Growth (2018-2023)
4.4 Europe Women's Oncology Detection Solutions Market Size Growth (2018-2023)
4.5 Middle East & Africa Women's Oncology Detection Solutions Market Size Growth (2018-2023)
5 Americas
5.1 Americas Women's Oncology Detection Solutions Market Size by Country (2018-2023)
5.2 Americas Women's Oncology Detection Solutions Market Size by Type (2018-2023)
5.3 Americas Women's Oncology Detection Solutions Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Women's Oncology Detection Solutions Market Size by Region (2018-2023)
6.2 APAC Women's Oncology Detection Solutions Market Size by Type (2018-2023)
6.3 APAC Women's Oncology Detection Solutions Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Women's Oncology Detection Solutions by Country (2018-2023)
7.2 Europe Women's Oncology Detection Solutions Market Size by Type (2018-2023)
7.3 Europe Women's Oncology Detection Solutions Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Women's Oncology Detection Solutions by Region (2018-2023)
8.2 Middle East & Africa Women's Oncology Detection Solutions Market Size by Type (2018-2023)
8.3 Middle East & Africa Women's Oncology Detection Solutions Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Women's Oncology Detection Solutions Market Forecast
10.1 Global Women's Oncology Detection Solutions Forecast by Regions (2024-2029)
10.1.1 Global Women's Oncology Detection Solutions Forecast by Regions (2024-2029)
10.1.2 Americas Women's Oncology Detection Solutions Forecast
10.1.3 APAC Women's Oncology Detection Solutions Forecast
10.1.4 Europe Women's Oncology Detection Solutions Forecast
10.1.5 Middle East & Africa Women's Oncology Detection Solutions Forecast
10.2 Americas Women's Oncology Detection Solutions Forecast by Country (2024-2029)
10.2.1 United States Women's Oncology Detection Solutions Market Forecast
10.2.2 Canada Women's Oncology Detection Solutions Market Forecast
10.2.3 Mexico Women's Oncology Detection Solutions Market Forecast
10.2.4 Brazil Women's Oncology Detection Solutions Market Forecast
10.3 APAC Women's Oncology Detection Solutions Forecast by Region (2024-2029)
10.3.1 China Women's Oncology Detection Solutions Market Forecast
10.3.2 Japan Women's Oncology Detection Solutions Market Forecast
10.3.3 Korea Women's Oncology Detection Solutions Market Forecast
10.3.4 Southeast Asia Women's Oncology Detection Solutions Market Forecast
10.3.5 India Women's Oncology Detection Solutions Market Forecast
10.3.6 Australia Women's Oncology Detection Solutions Market Forecast
10.4 Europe Women's Oncology Detection Solutions Forecast by Country (2024-2029)
10.4.1 Germany Women's Oncology Detection Solutions Market Forecast
10.4.2 France Women's Oncology Detection Solutions Market Forecast
10.4.3 UK Women's Oncology Detection Solutions Market Forecast
10.4.4 Italy Women's Oncology Detection Solutions Market Forecast
10.4.5 Russia Women's Oncology Detection Solutions Market Forecast
10.5 Middle East & Africa Women's Oncology Detection Solutions Forecast by Region (2024-2029)
10.5.1 Egypt Women's Oncology Detection Solutions Market Forecast
10.5.2 South Africa Women's Oncology Detection Solutions Market Forecast
10.5.3 Israel Women's Oncology Detection Solutions Market Forecast
10.5.4 Turkey Women's Oncology Detection Solutions Market Forecast
10.5.5 GCC Countries Women's Oncology Detection Solutions Market Forecast
10.6 Global Women's Oncology Detection Solutions Forecast by Type (2024-2029)
10.7 Global Women's Oncology Detection Solutions Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Women's Oncology Detection Solutions Product Offered
11.1.3 Roche Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Women's Oncology Detection Solutions Product Offered
11.2.3 Abbott Laboratories Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Abbott Laboratories Main Business Overview
11.2.5 Abbott Laboratories Latest Developments
11.3 Thermo Fisher Scientific, Inc.
11.3.1 Thermo Fisher Scientific, Inc. Company Information
11.3.2 Thermo Fisher Scientific, Inc. Women's Oncology Detection Solutions Product Offered
11.3.3 Thermo Fisher Scientific, Inc. Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.3.5 Thermo Fisher Scientific, Inc. Latest Developments
11.4 QIAGEN N.V.
11.4.1 QIAGEN N.V. Company Information
11.4.2 QIAGEN N.V. Women's Oncology Detection Solutions Product Offered
11.4.3 QIAGEN N.V. Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 QIAGEN N.V. Main Business Overview
11.4.5 QIAGEN N.V. Latest Developments
11.5 BGI
11.5.1 BGI Company Information
11.5.2 BGI Women's Oncology Detection Solutions Product Offered
11.5.3 BGI Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BGI Main Business Overview
11.5.5 BGI Latest Developments
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Bio-Rad Laboratories, Inc. Company Information
11.6.2 Bio-Rad Laboratories, Inc. Women's Oncology Detection Solutions Product Offered
11.6.3 Bio-Rad Laboratories, Inc. Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.6.5 Bio-Rad Laboratories, Inc. Latest Developments
11.7 Illumina, Inc.
11.7.1 Illumina, Inc. Company Information
11.7.2 Illumina, Inc. Women's Oncology Detection Solutions Product Offered
11.7.3 Illumina, Inc. Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Illumina, Inc. Main Business Overview
11.7.5 Illumina, Inc. Latest Developments
11.8 MolecularMD
11.8.1 MolecularMD Company Information
11.8.2 MolecularMD Women's Oncology Detection Solutions Product Offered
11.8.3 MolecularMD Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 MolecularMD Main Business Overview
11.8.5 MolecularMD Latest Developments
11.9 Invivoscribe, Inc.
11.9.1 Invivoscribe, Inc. Company Information
11.9.2 Invivoscribe, Inc. Women's Oncology Detection Solutions Product Offered
11.9.3 Invivoscribe, Inc. Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Invivoscribe, Inc. Main Business Overview
11.9.5 Invivoscribe, Inc. Latest Developments
11.10 BioAssay Systems
11.10.1 BioAssay Systems Company Information
11.10.2 BioAssay Systems Women's Oncology Detection Solutions Product Offered
11.10.3 BioAssay Systems Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 BioAssay Systems Main Business Overview
11.10.5 BioAssay Systems Latest Developments
11.11 Labcompare
11.11.1 Labcompare Company Information
11.11.2 Labcompare Women's Oncology Detection Solutions Product Offered
11.11.3 Labcompare Women's Oncology Detection Solutions Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Labcompare Main Business Overview
11.11.5 Labcompare Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1. Women's Oncology Detection Solutions Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Tissue Test
Table 3. Major Players of Blood Test
Table 4. Major Players of Others
Table 5. Women's Oncology Detection Solutions Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Women's Oncology Detection Solutions Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Table 8. Women's Oncology Detection Solutions Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Women's Oncology Detection Solutions Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Table 11. Global Women's Oncology Detection Solutions Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Women's Oncology Detection Solutions Revenue Market Share by Player (2018-2023)
Table 13. Women's Oncology Detection Solutions Key Players Head office and Products Offered
Table 14. Women's Oncology Detection Solutions Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Women's Oncology Detection Solutions Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Women's Oncology Detection Solutions Market Size Market Share by Regions (2018-2023)
Table 19. Global Women's Oncology Detection Solutions Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Women's Oncology Detection Solutions Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Women's Oncology Detection Solutions Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Women's Oncology Detection Solutions Market Size Market Share by Country (2018-2023)
Table 23. Americas Women's Oncology Detection Solutions Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Table 25. Americas Women's Oncology Detection Solutions Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Table 27. APAC Women's Oncology Detection Solutions Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Women's Oncology Detection Solutions Market Size Market Share by Region (2018-2023)
Table 29. APAC Women's Oncology Detection Solutions Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Table 31. APAC Women's Oncology Detection Solutions Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Table 33. Europe Women's Oncology Detection Solutions Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Women's Oncology Detection Solutions Market Size Market Share by Country (2018-2023)
Table 35. Europe Women's Oncology Detection Solutions Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Table 37. Europe Women's Oncology Detection Solutions Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Women's Oncology Detection Solutions Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Women's Oncology Detection Solutions Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Women's Oncology Detection Solutions Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Women's Oncology Detection Solutions
Table 46. Key Market Challenges & Risks of Women's Oncology Detection Solutions
Table 47. Key Industry Trends of Women's Oncology Detection Solutions
Table 48. Global Women's Oncology Detection Solutions Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Women's Oncology Detection Solutions Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Women's Oncology Detection Solutions Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Women's Oncology Detection Solutions Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Roche Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 53. Roche Women's Oncology Detection Solutions Product Offered
Table 54. Roche Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. Abbott Laboratories Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 58. Abbott Laboratories Women's Oncology Detection Solutions Product Offered
Table 59. Abbott Laboratories Main Business
Table 60. Abbott Laboratories Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Abbott Laboratories Latest Developments
Table 62. Thermo Fisher Scientific, Inc. Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 63. Thermo Fisher Scientific, Inc. Women's Oncology Detection Solutions Product Offered
Table 64. Thermo Fisher Scientific, Inc. Main Business
Table 65. Thermo Fisher Scientific, Inc. Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Thermo Fisher Scientific, Inc. Latest Developments
Table 67. QIAGEN N.V. Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 68. QIAGEN N.V. Women's Oncology Detection Solutions Product Offered
Table 69. QIAGEN N.V. Main Business
Table 70. QIAGEN N.V. Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. QIAGEN N.V. Latest Developments
Table 72. BGI Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 73. BGI Women's Oncology Detection Solutions Product Offered
Table 74. BGI Main Business
Table 75. BGI Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. BGI Latest Developments
Table 77. Bio-Rad Laboratories, Inc. Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 78. Bio-Rad Laboratories, Inc. Women's Oncology Detection Solutions Product Offered
Table 79. Bio-Rad Laboratories, Inc. Main Business
Table 80. Bio-Rad Laboratories, Inc. Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Bio-Rad Laboratories, Inc. Latest Developments
Table 82. Illumina, Inc. Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 83. Illumina, Inc. Women's Oncology Detection Solutions Product Offered
Table 84. Illumina, Inc. Main Business
Table 85. Illumina, Inc. Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Illumina, Inc. Latest Developments
Table 87. MolecularMD Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 88. MolecularMD Women's Oncology Detection Solutions Product Offered
Table 89. MolecularMD Main Business
Table 90. MolecularMD Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. MolecularMD Latest Developments
Table 92. Invivoscribe, Inc. Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 93. Invivoscribe, Inc. Women's Oncology Detection Solutions Product Offered
Table 94. Invivoscribe, Inc. Main Business
Table 95. Invivoscribe, Inc. Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Invivoscribe, Inc. Latest Developments
Table 97. BioAssay Systems Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 98. BioAssay Systems Women's Oncology Detection Solutions Product Offered
Table 99. BioAssay Systems Main Business
Table 100. BioAssay Systems Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. BioAssay Systems Latest Developments
Table 102. Labcompare Details, Company Type, Women's Oncology Detection Solutions Area Served and Its Competitors
Table 103. Labcompare Women's Oncology Detection Solutions Product Offered
Table 104. Labcompare Women's Oncology Detection Solutions Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Labcompare Main Business
Table 106. Labcompare Latest Developments
List of Figures
Figure 1. Women's Oncology Detection Solutions Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Women's Oncology Detection Solutions Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Women's Oncology Detection Solutions Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Women's Oncology Detection Solutions Sales Market Share by Country/Region (2022)
Figure 8. Women's Oncology Detection Solutions Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Women's Oncology Detection Solutions Market Size Market Share by Type in 2022
Figure 10. Women's Oncology Detection Solutions in Hospital
Figure 11. Global Women's Oncology Detection Solutions Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Women's Oncology Detection Solutions in Third-party Medical Examination Institution
Figure 13. Global Women's Oncology Detection Solutions Market: Third-party Medical Examination Institution (2018-2023) & ($ Millions)
Figure 14. Women's Oncology Detection Solutions in Others
Figure 15. Global Women's Oncology Detection Solutions Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Women's Oncology Detection Solutions Market Size Market Share by Application in 2022
Figure 17. Global Women's Oncology Detection Solutions Revenue Market Share by Player in 2022
Figure 18. Global Women's Oncology Detection Solutions Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Women's Oncology Detection Solutions Market Size 2018-2023 ($ Millions)
Figure 20. APAC Women's Oncology Detection Solutions Market Size 2018-2023 ($ Millions)
Figure 21. Europe Women's Oncology Detection Solutions Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Women's Oncology Detection Solutions Market Size 2018-2023 ($ Millions)
Figure 23. Americas Women's Oncology Detection Solutions Value Market Share by Country in 2022
Figure 24. United States Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Women's Oncology Detection Solutions Market Size Market Share by Region in 2022
Figure 29. APAC Women's Oncology Detection Solutions Market Size Market Share by Type in 2022
Figure 30. APAC Women's Oncology Detection Solutions Market Size Market Share by Application in 2022
Figure 31. China Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Women's Oncology Detection Solutions Market Size Market Share by Country in 2022
Figure 38. Europe Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Figure 39. Europe Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Figure 40. Germany Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Women's Oncology Detection Solutions Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Women's Oncology Detection Solutions Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 54. APAC Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 55. Europe Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 57. United States Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 58. Canada Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 61. China Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 62. Japan Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 63. Korea Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 65. India Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 66. Australia Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 67. Germany Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 68. France Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 69. UK Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 70. Italy Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 71. Russia Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 72. Spain Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 75. Israel Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Women's Oncology Detection Solutions Market Size 2024-2029 ($ Millions)
Figure 78. Global Women's Oncology Detection Solutions Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Women's Oncology Detection Solutions Market Size Market Share Forecast by Application (2024-2029)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

本レポートと同じKEY WORD(oncology)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る